[1]WANG TL, ZHANG TH.Advances in pathological classification of viral hepatitis[J].Chin J Pathol, 1996, 25 (2) :67-69. (in Chinese) 王泰龄, 张泰和.病毒性肝炎病理分类的进展[J].中华病理学杂志, 1996, 25 (2) :67-69.
|
[2] ZHANG TH, ZHOU XJ.Pratical tiver pathology[M].Shanghai:Shanghai Scientific and Technological Literarure Press, 1995. (in Chinese) 张泰和, 周晓军.实用肝脏病理学[M].上海:上海科技文献出版社, 1995.
|
[3]WANG EB.New trends in diagnosis, grading and staging of chronic hepatitis[J].Chin J Hepatol, 1995, 3 (1) :4-6. (in Chinese) 王恩宝.慢性肝炎的诊断、分级与分期的新动态[J].中华肝脏病杂志, 1995, 3 (1) :4-6.
|
[4]ZHOU GD, ZHAO YL, ZHAO JM, et al.Hepatic steatosis associated with the progression of chronic hepatitis C[J/CD].Chin J Clinicians:Electronic Edition, 2012, 6 (6) :1470-1472. (in Chinese) 周光德, 赵雨来, 赵景民, 等.肝脂肪变性促进慢性丙型肝炎病程进展的研究[J/CD].中华临床医师杂志:电子版, 2012, 6 (6) :1470-1472.
|
[5]ZHANG P, ZHAO XY.Clinical characteristics of chronic HBV/HCV infection complicated with mild fatty liver disease[J].Heilongjiang Med Pharm, 2017, 40 (5) :140-141. (in Chinese) 张盼, 赵晓迎.慢性HBV/HCV感染合并轻度脂肪肝病变的临床特点分析[J].黑龙江医药科学, 2017, 40 (5) :140-141.
|
[6]ZHANG TH, ZHOU XJ.Research status ot HCV pathomorphology[J].Infect Dis Info, 1995, 8 (4) :156. (in Chinese) 张泰和, 周晓军.丙型病毒性肝炎病理形态的研究现状[J].传染病信息, 1995, 8 (4) :156.
|
[7]KLEINER DE.The histopathological evaluation of drug-induced liver injury[J].Histopathology, 2017, 70 (1) :81-93.
|
[8]DU HJ.Clinical and histopathological features of drug-induced liver injury and the role of immunocyte[D].Hebei:Hebei Med Univ, 2016:1-27. (in Chinese) 杜慧娟.药物性肝损伤的临床病理学特点及免疫细胞在发病中作用的研究[D].河北:河北医科大学, 2016:1-27.
|
[9]ZHOU XJ, ZHANG LH.Diagnostic pathology of liver disease[M].Nanjing:Phoenix Science Press, 2006. (in Chinese) 周晓军, 张丽华.肝脏诊断病理学[M].南京:江苏科学技术出版社, 2006.
|
[10]HENNES EM, ZENIYA M, CZAJA AJ, et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology, 2008, 48 (1) :169-176.
|
[11]JAING LL.Expression of MUM-1 and CD138 in autommune hepatitis and its significance[D].Suzhou:Soochow Univ, 2015:1-36. (in Chinese) 蒋丽琳.MUM-1和CD138在自身免疫性肝炎中的表达及其临床意义[D].苏州:苏州大学, 2015:1-36.
|
[12] Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 31 (12) :1980-1988. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1980-1988.
|
[13]YOU Z, WANG Q, BIAN Z, et al.The immunopathplogy of liver granulomas in primary biliary cirrhosis[J].J Autoimmun, 2012, 39 (3) :216-221.
|
[14]KHAN FM, KOMARLA AR, MENDOZA PG, et al.Keratin19demonstration of canal of Hering loss in primary biliary cirrhosis:“minimal change PBC”[J].Hepatology, 2013, 57 (2) :700-707.
|
[15]MOREIRA RK, REVETTA F, KOEHLER E, et al.Diagnostic utility of Ig G and Ig M immunohistochemistry in autoimmune liver disease[J].World J Gastroenterol, 2010, 16 (4) :453-457.
|
[16]SHEN B, ZHOU XG.Detection of Ig M and Ig G in plasma cells of liver biopsy specimens from primary biliary cirrhosis and autoimmune hepatitis by immunohistochemistry[J].Chin J Gastroenterol Hepatol, 2010, 19 (10) :901-904. (in Chinese) 沈冰, 周新刚.原发性胆汁性肝硬化和自身免疫性肝炎肝组织中浆细胞Ig M和Ig G的免疫组化检测[J].胃肠病学和肝病学杂志, 2010, 19 (10) :901-904.
|
[17]MIAO Q, CHEN XY.Pathological features of autoimmune liver diseases[J].Chin J Gastroenterol, 2018, 23 (5) :287-292. (in Chinese) 苗琪, 陈晓宇.自身免疫性肝病相关病理特征[J].胃肠病学, 2018, 23 (5) :287-292.
|
[18]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary sclerosing cholangitis (2015) [J].JClin Hepatol, 2016, 32 (1) :23-31. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性硬化性胆管炎诊断和治疗专家共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :23-31.
|